Teledermatology in the provision of biologics through <scp>COVID</scp>‐19 in a rural dermatology practice—A retrospective review

Wong, Xin Lin; Farrell, Joshua; Satchell, Andrew C.; Sebaratnam, Deshan F

doi:10.1111/ajd.14096

Aust J Dermatology

2023

DOI: 10.1111/ajd.14096

|View full text |Cite

Teledermatology in the provision of biologics through COVID‐19 in a rural dermatology practice—A retrospective review

Xin Lin Wong

Joshua Farrell

Andrew C. Satchell

et al.

Abstract: COVID‐19 compounded existing barriers to healthcare for rural patients. We completed a retrospective chart review of patients receiving Pharmaceutical Benefits Scheme subsidised biologics at a Modified Monash Model 3 dermatology practice during the pandemic and examined factors contributing to successful continuation of care, particularly teledermatology. Our experience is instructive in the provision of medical dermatology to regional patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Experience of dermatologic biologic therapy use and associated opportunistic infection management in Australia's tropical north

Adams,

Metin,

Stevenson

2024

Aust J Dermatology

View full text Add to dashboard Cite

Background/ObjectivesRoyal Darwin Hospital (RDH) is the sole public dermatology service in the Northern Territory (NT). Prescription of biologic therapies (BT) in the NT is uniquely challenging, with remote populations carrying a high tropical disease burden. The aim of this audit is to examine the demographics and outcomes of patients on BT for dermatologic conditions.MethodsRetrospective case note review of patients receiving BT through the RDH Dermatology department between August 2021 and October 2023. Data analysed were demographics, location, dermatological diagnosis and serology status.ResultsIn this audit, 115 patients were included. Age range of 13–91 years, mean of 51.1 years (±14.7), 52 (45.2%) patients were female and 8 (7.8%) identified as First Nations Australian. A large geographical area was serviced, with a primary address between 1 and 1496 km from RDH. Eighteen patients (15.7%) have discontinued BT completely. There was a statistically significant relationship between cessation of BT and increased distance of primary residence from RDH (p < 0.0007). Eighteen patients (15.7%) required management of infections identified in opportunistic infection screening. These infections were strongyloidiasis, tuberculosis, melioidosis and hepatitis B.ConclusionsThere is significant anxiety surrounding BT and tropical infections, including in returning travellers in southern Australian states. There has been particular interest in strongyloidiasis infection, as dupilumab acts on the Th2 immunity mechanism critical to parasitic infection response. This audit exhibits the unique experience of dermatological care in a tropical setting, demonstrating how BT can be used safely and how, when identified, these tropical infections can be successfully managed.

show abstract

Experience of dermatologic biologic therapy use and associated opportunistic infection management in Australia's tropical north

Adams,

Metin,

Stevenson

2024

Aust J Dermatology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Teledermatology in the provision of biologics through COVID‐19 in a rural dermatology practice—A retrospective review

Cited by 1 publication

References 13 publications

Experience of dermatologic biologic therapy use and associated opportunistic infection management in Australia's tropical north

Experience of dermatologic biologic therapy use and associated opportunistic infection management in Australia's tropical north

Contact Info

Product

Resources

About